Amy Steger
Women's Health · Cedar Rapids, IANPI 1952728735
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.3% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations.
Across 127 payments — averaging $18.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$483
- AbbVie$439
- Exeltis, USA Inc.$127
- Pfizer$126
- Sumitomo Pharma America, Inc.$113
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$102
- plus $955 from 22 others
What the payments were for
- Food & beverage$2,25896%
- Education$864%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 19 | $483 |
| AbbVie | 30 | $439 |
| Exeltis, USA Inc. | 7 | $127 |
| Pfizer | 7 | $126 |
| Sumitomo Pharma America, Inc. | 2 | $113 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $102 |
| Coopersurgical, Inc. | 5 | $96 |
| Mayne Pharma Commercial LLC | 7 | $87 |
| Therapeuticsmd, Inc. | 5 | $77 |
| Merck | 4 | $67 |
| Bayer | 4 | $59 |
| Novo Nordisk | 3 | $58 |
| Myovant Sciences Inc. | 3 | $54 |
| Biogen | 3 | $52 |
| Lilly USA, LLC | 3 | $51 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $49 |
| Octapharma USA, Inc. | 2 | $48 |
| Amgen | 3 | $44 |
| Biohaven Pharmaceuticals, Inc. | 2 | $43 |
| Hologic Sales And Service, LLC | 1 | $30 |
| Axonics, Inc. | 1 | $21 |
| Ironwood Pharmaceuticals, Inc | 1 | $19 |
| Organon | 1 | $19 |
| Vertex | 1 | $19 |
| AstraZeneca | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Agile Therapeutics, Inc. | 1 | $13 |
| Urovant Sciences Inc | 1 | $12 |
How this compares
$2,344 in reported general payments places this provider in the 85th percentile of 58 women's health providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other women's health in Cedar Rapids
- Nicole MyersCedar Rapids$206
- Jennifer BurgettCedar Rapids$126
- Rebecca HammesCedar Rapids$103
- Nicole BaccamCedar Rapids$72
- Christina OsbornCedar Rapids$70
- Melissa BecwarCedar Rapids$44
- Sara OlmsteadCedar Rapids$38
- Darci LewisDes Moines$17K
- Tami SheldonDavenport$8K
- Susan SchaferDavenport$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.